Retrospective analysis of activity of pembrolizumab (pembro) in melanoma patients (pts) with brain metastasis (BM). This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
This study enrolled oncology and hematology patients who had retained their port following completion of anticancer treatment. Clinical data were extracted for 1,059 participants. The primary end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results